Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP
Laura García‐González(Centre National de la Recherche Scientifique), Santiago Rivera(Aix-Marseille Université)
Cited by 82
Related Papers
Mutations in specific domains of MT5-MMP prevent the accumulation of toxic APP metabolites and serve as templates for peptide-based therapeutics in human in vitro models of Alzheimer's disease
|HAL (Le Centre pour la Communication Scientifique Directe)|2024|0